Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutrilite Brahmi is a herbal dietary supplement developed and marketed by Amway under its Nutrilite brand. The product features a standardized extract of *Bacopa monnieri* (Brahmi), a plant traditionally used in Ayurvedic medicine for its cognitive-enhancing properties. It is formulated to provide a consistent level of 20% bacosides, which are the primary active compounds responsible for its biological activity. Nutrilite Brahmi is intended to support mental agility, memory, concentration, and alertness by promoting the healthy functioning of the central nervous system. The supplement is produced using certified organic herbs, non-GMO seeds, and DNA fingerprinting technology to ensure the purity and correct identification of the botanical species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutrilite Brahmi.